lobbying_activities: 2999968

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2999968	07d7c0ab-48b0-43ef-b993-3e1b490c6480	Q2	RED+BLUE STRATEGIES	400693064	QUEST DIAGNOSTICS INCORPORATED	2023	second_quarter	MMM	Issues related to specific, federally-reimbursed drug testing protocols. H.R. 1835- The Saving Access to Laboratory Services Act - Issues related to the treatment of clinical labs in the Medicare program. Rules, regulations and guidance related to the end of the public health emergency and the treatment of Covid testing, pathology and other related issues.	HOUSE OF REPRESENTATIVES,SENATE	80000		0	0	2023-07-08T14:04:15-04:00